Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Bladder Transitional Cell Carcinoma
100%
Ki-67
100%
Cyclin D1 (CCND1)
100%
Tumor
53%
P53 Expression
20%
Cyclin
13%
Bladder Tumor
13%
Multivariate Analysis
13%
T4 Tumor
13%
Muscle-invasive Disease
13%
Cyclin-dependent Kinase
13%
Median Value
13%
Clinical Outcomes
6%
Clinical Course
6%
Overall Survival
6%
Tumor Stage
6%
Positive Staining
6%
Immunohistochemistry
6%
Cell Proliferation
6%
Histological Grade
6%
Muscle-invasive
6%
Invasive Tumors
6%
Prognostic Indicator
6%
Newly Diagnosed
6%
Stage Progression
6%
Nuclear Staining
6%
Tumor Recurrence
6%
Well-differentiated
6%
Ki-67 Expression
6%
Wild-type p53
6%
Paraffin Section
6%
Low Stage
6%
Risk Analysis
6%
T1 Tumor
6%
G1-S Transition
6%
Progression Rate
6%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
6%
Cytoplasmic Staining
6%
Staining Patterns
6%
Medicine and Dentistry
Transitional Cell Carcinoma
100%
Bladder
100%
Protein P53
100%
Cyclin D1
100%
Tumor
80%
Diseases
20%
Bladder Tumor
13%
Multivariate Analysis
13%
Cancer Staging
6%
Overall Survival
6%
Immunohistochemistry
6%
Cell Proliferation
6%
Tumor Recurrence
6%
Disease Course
6%
S Phase
6%
Cyclin Dependent Kinase Inhibitor
6%
Cyclin
6%
Cyclin-Dependent Kinase Complex
6%
Paraffin Wax
6%
Cyclin-Dependent Kinase
6%
Proliferating Cell Nuclear Antigen
6%
Veterinary Science and Veterinary Medicine
Transitional Cell Carcinoma
100%
P53
100%
Tumor
100%
Muscle
20%
Diseases
20%
Cancer Stages
6%
Immunohistochemistry
6%
Risk Factor
6%